SOLACE

MSB is excited to be a current partner in the Strengthening the screening of Lung Cancer in Europe (SOLACE) project (a new EU4Health project) under the Europe’s Beating Cancer Plan. It will facilitate implementation of lung cancer screening programmes across Europe. SOLACE is working to break down the barriers to cancer screening (e.g. hard to reach population, social and economic challenged groups) to ensure people gain the access and knowledge needed. The SOLACE project was officially launched in April, 2023 and will run for three years.

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No. 101101187.

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
Homepage - SOLACE (europeanlung.org)

“We have the evidence, we have the political will through Europe’s Beating cancer plan, and now – with the SOLACE project – we have the means to be able to scale up and strengthen lung cancer screening programmes across the European Union. I am proud that European Respiratory Society members and patients through Lungs Europe will have a key role in making this project an important milestone in the battle to save lives from lung cancer.”

Prof. Torsten Blum, SOLACE Coordination Team

Disclaimer:
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

This project is co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101101187

Visit the SOLACE website